Form 8-K - Current report:
SEC Accession No. 0001193125-18-278768
Filing Date
2018-09-20
Accepted
2018-09-20 16:24:08
Documents
11
Period of Report
2018-09-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d625276d8k.htm 8-K 17176
2 EX-10.1 d625276dex101.htm EX-10.1 610434
3 GRAPHIC g625276page082.jpg GRAPHIC 237954
4 GRAPHIC g625276page083.jpg GRAPHIC 233198
5 GRAPHIC g625276page084.jpg GRAPHIC 287423
6 GRAPHIC g625276page085.jpg GRAPHIC 225259
7 GRAPHIC g625276page090.jpg GRAPHIC 268956
8 GRAPHIC g625276page091.jpg GRAPHIC 248002
9 GRAPHIC g625276page092.jpg GRAPHIC 209852
10 GRAPHIC g625276page098.jpg GRAPHIC 244373
11 GRAPHIC g625276page101.jpg GRAPHIC 193804
  Complete submission text file 0001193125-18-278768.txt   3589485
Mailing Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025
Business Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025 6509638580
Versartis, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 181079693
SIC: 2834 Pharmaceutical Preparations